AI assistant
Sending…
IRADIMED CORP — Director's Dealing 2024
Jun 4, 2024
32324_dirs_2024-06-04_a436f665-ff85-47de-8a00-66a53d94bfcf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2024-06-03
Reporting Person: ALLEN MONTY K (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-03 | Common Stock | S | 1947 | $43.3654 | Disposed | 18053 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $43.17 to $43.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from IRADIMED CORP
Interim / Quarterly Report
2026
May 1
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Feb 13
Regulatory Filings
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 13
Director's Dealing
2026
Jan 6